EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ECG - US3004261034 - Common Stock
89.18 USD
+3.62 (+4.23%)
89.18 USD
0 (0%)
ECG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Construction & Engineering industry. ECG has an excellent financial health rating, but there are some minor concerns on its profitability. ECG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ECG had positive earnings in the past year.
In the past year ECG had a positive cash flow from operations.
1.2 Ratios
ECG's Return On Assets of 11.14% is fine compared to the rest of the industry. ECG outperforms 77.78% of its industry peers.
ECG has a better Return On Equity (31.58%) than 81.48% of its industry peers.
ECG has a better Return On Invested Capital (19.09%) than 83.33% of its industry peers.
ECG had an Average Return On Invested Capital over the past 3 years of 19.20%. This is above the industry average of 16.29%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.14% | ||
| ROE | 31.58% | ||
| ROIC | 19.09% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.18%, ECG is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
In the last couple of years the Profit Margin of ECG has declined.
ECG's Operating Margin of 6.92% is in line compared to the rest of the industry. ECG outperforms 57.41% of its industry peers.
ECG's Operating Margin has declined in the last couple of years.
ECG's Gross Margin of 12.10% is on the low side compared to the rest of the industry. ECG is outperformed by 64.81% of its industry peers.
In the last couple of years the Gross Margin of ECG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.92% | ||
| PM (TTM) | 5.18% | ||
| GM | 12.1% |
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ECG is creating value.
The number of shares outstanding for ECG remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ECG has a worse debt to assets ratio.
2.2 Solvency
ECG has an Altman-Z score of 5.89. This indicates that ECG is financially healthy and has little risk of bankruptcy at the moment.
ECG's Altman-Z score of 5.89 is amongst the best of the industry. ECG outperforms 81.48% of its industry peers.
The Debt to FCF ratio of ECG is 2.14, which is a good value as it means it would take ECG, 2.14 years of fcf income to pay off all of its debts.
ECG has a better Debt to FCF ratio (2.14) than 75.93% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that ECG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, ECG is in line with its industry, outperforming 59.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.14 | ||
| Altman-Z | 5.89 |
ROIC/WACC1.81
WACC10.55%
2.3 Liquidity
ECG has a Current Ratio of 1.76. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
ECG has a better Current ratio (1.76) than 85.19% of its industry peers.
ECG has a Quick Ratio of 1.69. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ECG (1.69) is better than 90.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
ECG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.30%.
ECG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.37% yearly.
ECG shows a decrease in Revenue. In the last year, the revenue decreased by -0.16%.
The Revenue has been growing by 11.57% on average over the past years. This is quite good.
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.98%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%29.68%
3.2 Future
The Earnings Per Share is expected to grow by 15.65% on average over the next years. This is quite good.
Based on estimates for the next years, ECG will show a quite strong growth in Revenue. The Revenue will grow by 16.23% on average per year.
EPS Next Y28.92%
EPS Next 2Y18.29%
EPS Next 3Y15.65%
EPS Next 5YN/A
Revenue Next Year30.24%
Revenue Next 2Y19.81%
Revenue Next 3Y16.23%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 25.26, the valuation of ECG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ECG indicates a somewhat cheap valuation: ECG is cheaper than 75.93% of the companies listed in the same industry.
ECG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.60.
The Price/Forward Earnings ratio is 22.60, which indicates a rather expensive current valuation of ECG.
72.22% of the companies in the same industry are more expensive than ECG, based on the Price/Forward Earnings ratio.
ECG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.26 | ||
| Fwd PE | 22.6 |
4.2 Price Multiples
ECG's Enterprise Value to EBITDA ratio is in line with the industry average.
ECG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ECG is cheaper than 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.09 | ||
| EV/EBITDA | 16.67 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ECG's earnings are expected to grow with 15.65% in the coming years.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y18.29%
EPS Next 3Y15.65%
5. Dividend
5.1 Amount
No dividends for ECG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
89.18
+3.62 (+4.23%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners88.33%
Inst Owner Change4.15%
Ins Owners0.3%
Ins Owner Change0.93%
Market Cap4.55B
Revenue(TTM)3.49B
Net Income(TTM)180.96M
Analysts80
Price Target108.89 (22.1%)
Short Float %2.54%
Short Ratio2.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)75.29%
Min EPS beat(2)72.75%
Max EPS beat(2)77.83%
EPS beat(4)3
Avg EPS beat(4)53.11%
Min EPS beat(4)-3.53%
Max EPS beat(4)77.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.59%
Min Revenue beat(2)17.63%
Max Revenue beat(2)23.55%
Revenue beat(4)4
Avg Revenue beat(4)18.41%
Min Revenue beat(4)11.43%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.03%
PT rev (3m)26.58%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)29.88%
EPS NY rev (1m)22.03%
EPS NY rev (3m)22.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.46%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.26 | ||
| Fwd PE | 22.6 | ||
| P/S | 1.3 | ||
| P/FCF | 34.09 | ||
| P/OCF | 24.03 | ||
| P/B | 7.94 | ||
| P/tB | 10.58 | ||
| EV/EBITDA | 16.67 |
EPS(TTM)3.53
EY3.96%
EPS(NY)3.95
Fwd EY4.43%
FCF(TTM)2.62
FCFY2.93%
OCF(TTM)3.71
OCFY4.16%
SpS68.51
BVpS11.23
TBVpS8.43
PEG (NY)0.87
PEG (5Y)N/A
Graham Number29.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.14% | ||
| ROE | 31.58% | ||
| ROCE | 25.96% | ||
| ROIC | 19.09% | ||
| ROICexc | 22.73% | ||
| ROICexgc | 27.82% | ||
| OM | 6.92% | ||
| PM (TTM) | 5.18% | ||
| GM | 12.1% | ||
| FCFM | 3.82% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-Score7
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.14 | ||
| Debt/EBITDA | 1 | ||
| Cap/Depr | 199.03% | ||
| Cap/Sales | 1.6% | ||
| Interest Coverage | 11.49 | ||
| Cash Conversion | 70.13% | ||
| Profit Quality | 73.74% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 5.89 |
F-Score7
WACC10.55%
ROIC/WACC1.81
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.98%
EPS Next Y28.92%
EPS Next 2Y18.29%
EPS Next 3Y15.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%29.68%
Revenue Next Year30.24%
Revenue Next 2Y19.81%
Revenue Next 3Y16.23%
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year57.36%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A
EVERUS CONSTRUCTION GROUP / ECG FAQ
Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?
ChartMill assigns a fundamental rating of 5 / 10 to ECG.
What is the valuation status for ECG stock?
ChartMill assigns a valuation rating of 4 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Fairly Valued.
How profitable is EVERUS CONSTRUCTION GROUP (ECG) stock?
EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 4 / 10.
What is the valuation of EVERUS CONSTRUCTION GROUP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 25.26 and the Price/Book (PB) ratio is 7.94.
What is the expected EPS growth for EVERUS CONSTRUCTION GROUP (ECG) stock?
The Earnings per Share (EPS) of EVERUS CONSTRUCTION GROUP (ECG) is expected to grow by 28.92% in the next year.